Directory UMM :Data Elmu:jurnal:A:Atherosclerosis:Vol152.Issue2.Oct2000:
Atherosclerosis 152 (2000) 537 – 541
www.elsevier.com/locate/atherosclerosis
Author index
Volume 152 (2000)
Abbasi, F., see Chen, N.G. 152, 203
Ablondi, F., see Denti, L. 152, 159
Adler, Y., M. Vaturi, N. Fink, D. Tanne, Y. Shapira, D. Weisenberg,
N. Sela, A. Sagie, Association between mitral annulus calcification
and aortic atheroma: a prospective transesophageal echocardiographic study 152, 451
Adlouni, A., M. El Messal, R. Saı¨le, H.-J. Parra, J.-C. Fruchart, N.
Ghalim, Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein
AI-containing lipoprotein particles 152, 433
Aguilar-Salinas, C.A., F.J. Go´mez-Pe´rez, C. Posadas-Romero, C.
Va´zquez-Cha´vez, E. Meaney, A. Gulı´as-Herrero, L.E. Guille´n, A.
Alvarado Vega, E. Mendoza Pe´rez, L. Eduardo Romero-Nava, R.
Ange´lica Go´mez-Dı´az, S. Salinas-Orozco, R. Moguel, G. Novoa,
Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study 152, 489
Akishita, M., see Ishikawa, M. 152, 97
Akita, H., see Rikitake, Y. 152, 79
Alvarado Vega, A., see Aguilar-Salinas, C.A. 152, 489
Amiral, J., see Blann, A.D. 152, 29
Amouyel, P., see Luc, G. 152, 399
Anami, Y., see Takemura, T. 152, 347
Ange´lica Go´mez-Dı´az, R., see Aguilar-Salinas, C.A. 152, 489
Angelucci, D., see Baccante, G. 152, 51
Argimon, J.M., see Salazar, A. 152, 497
Arveiler, D., see Luc, G. 152, 399
Aston, C.E., see Kamboh, M.I. 152, 193
Atsumi, T., see Yasuda, S. 152, 337
Aviv, A., see Okuda, K. 152, 391
Aviv, H., see Okuda, K. 152, 391
Azhar, S., see Chen, N.G. 152, 203
Baccante, G., G. Mincione, C. Di Febbo, A. Coppa, D. Angelucci,
D. Lapenna, F. Cuccurullo, G. Colletta, E. Porreca, Increased type
II transforming growth factor-b receptor expression in liver cells
during cholesterol challenge 152, 51
Bai, H.-z., see Yamakawa, T. 152, 287
Bak, A.A.A., see Westendorp, I.C.D. 152, 149
Baraona, E., see Navder, K.P. 152, 89
Bard, J.-M., see Luc, G. 152, 399
Baur, R., see Kotzerke, J. 152, 35
Beisiegel, U., see Schiele, F. 152, 475
Belcaro, G., see Leng, G.C. 152, 167
Benditt, E.P., see O’Brien, E.R. 152, 117
Benedetti, R., see Denti, L. 152, 159
Berenson, G.S., see Freedman, D.S. 152, 441
Bethell, H., see Li, C.G. 152, 249
Bhatnagar, D., see Li, C.G. 152, 249
Biwa, T., see Takemura, T. 152, 347
Blann, A.D., J. Amiral, C.N. McCollum, G.Y.H. Lip, Differences in
free and total tissue factor pathway inhibitor, and tissue factor in
peripheral artery disease compared to healthy controls 152, 29
PII: S0021-9150(00)00650-X
Bo¨l, G.-F., see Brigelius-Flohe´, R. 152, 307
Bonardo, B., see Lopez, S. 152, 359
Bonavita, C.D., see Brites, F.D. 152, 181
Bots, M.L., see Westendorp, I.C.D. 152, 149
Boucher, B., see Mott, S. 152, 457
Bowman, B.A., see Freedman, D.S. 152, 441
Brigelius-Flohe´, R., S. Maurer, K. Lo¨tzer, G.-F. Bo¨l, H. Kallionpa¨a¨,
P. Lehtolainen, H. Viita, S. Yla¨-Herttuala, Overexpression of
PHGPx inhibits hydroperoxide-induced oxidation, NFkB activation and apoptosis and affects oxLDL-mediated proliferation of
rabbit aortic smooth muscle cells 152, 307
Brites, F.D., C.D. Bonavita, C. De Geitere, M. Cloe¨s, B. Delfly, M.J.
Yael, J.-C. Fruchart, R.W. Wikinski, G.R. Castro, Alterations in
the main steps of reverse cholesterol transport in male patients with
primary hypertriglyceridemia and low HDL-cholesterol levels 152, 181
Bruschieri, L., see Denti, L. 152, 159
Buchmann, I., see Kotzerke, J. 152, 35
Byrne, C.D., see Halsall, D.J. 152, 9
Calabresi, L., see Sirtori, C.R. 152, 1
Calder, P.C., see Miles, E.A. 152, 43
Calleja, L., M.C. Trallero, C. Carrizosa, M.T. Me´ndez, E. PalaciosAlaiz, J. Osada, Effects of dietary fat amount and saturation on the
regulation of hepatic mRNA and plasma apolipoprotein A-I in
rats 152, 69
Candigliota, M., see Perticone, F. 152, 511
Carantoni, M., see Chen, N.G. 152, 203
Carrizosa, C., see Calleja, L. 152, 69
Castro, G.R., see Brites, F.D. 152, 181
Cecchetti, A., see Denti, L. 152, 159
Ceravolo, R., see Perticone, F. 152, 511
Chakko, S.C., see Lan Hsia, S. 152, 469
Chassereau, C., see Lopes-Virella, M.F. 152, 107
Chello, M., see Perticone, F. 152, 511
Chen, N.G., S. Azhar, F. Abbasi, M. Carantoni, G.M. Reaven, The
relationship between plasma glucose and insulin responses to oral
glucose, LDL oxidation, and soluble intercellular adhesion
molecule-1 in healthy volunteers 152, 203
Chiba, H., see Yasuda, S. 152, 337
Chisholm, A., see Wallace, A.J. 152, 327
Chou, S.-C., see Teng, Y.-N. 152, 385
Cloe¨s, M., see Brites, F.D. 152, 181
Cloro, C., see Perticone, F. 152, 511
Coelingh Bennink, H.J.T., see Westendorp, I.C.D. 152, 149
Colletta, G., see Baccante, G. 152, 51
Coppa, A., see Baccante, G. 152, 51
Corella, D., C. Sa´iz, M. Guille´n, O. Portole´s, F. Mulet, J.I. Gonza´lez,
J.M. Ordova´s, Association of TaqIB polymorphism in the
cholesteryl ester transfer protein gene with plasma lipid levels in a
healthy Spanish population 152, 367
538
Author index 6ol. 152 (2000)
Cortellini, P., see Denti, L. 152, 159
Cuccurullo, F., see Baccante, G. 152, 51
De Backer, G., see Schiele, F. 152, 475
De Bacquer, D., see Schiele, F. 152, 475
deBono, D.P., see Salame, M.Y. 152, 19
De Geitere, C., see Brites, F.D. 152, 181
de Kleijn, M.J.J., see Westendorp, I.C.D. 152, 149
Delfly, B., see Brites, F.D. 152, 181
Demacker, P.N.M., see Kroon, A.A. 152, 519
de Man, F.H., R. Nieuwland, A. van der Laarse, F. Romijn, A.H.M.
Smelt, J.A. Gevers Leuven, A. Sturk, Activated platelets in patients
with severe hypertriglyceridemia: effects of triglyceride-lowering
therapy 152, 407
Denti, L., G. Pasolini, P. Cortellini, L. Sanfelici, R. Benedetti, A.
Cecchetti, S. Ferretti, L. Bruschieri, F. Ablondi, G. Valenti,
Changes in HDL-cholesterol and lipoprotein Lp(a) after 6-month
treatment with finasteride in males affected by benign prostatic
hyperplasia (BPH) 152, 159
Dhanjil, S., see Leng, G.C. 152, 167
Di Febbo, C., see Baccante, G. 152, 51
Ducimetiere, P., see Luc, G. 152, 399
Duncan, R., see Lan Hsia, S. 152, 469
Duvillard, L., F. Pont, E. Florentin, P. Gambert, B. Verge`s, Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic
abnormalities in non-insulin-dependent diabetes mellitus 152, 229
Ea-Kim, L., see Ghanam, K. 152, 59
Ebrahim, S., see Leng, G.C. 152, 167
Eden, J.A., see Howes, J.B. 152, 143
Eduardo Romero-Nava, L., see Aguilar-Salinas, C.A.
Ehnholm, C., see Schiele, F. 152, 475
Ehnholm, C., see Tahvanainen, E. 152, 317
Ehnholm, C., see Tammi, A. 152, 135
El Messal, M., see Adlouni, A. 152, 433
Enockson, C., see Lopes-Virella, M.F. 152, 107
Evans, A., see Luc, G. 152, 399
Evans, A., see Schiele, F. 152, 475
152, 489
Farinaro, E., see Tahvanainen, E. 152, 317
Ferretti, S., see Denti, L. 152, 159
Fink, N., see Adler, Y. 152, 451
Fiol, C., see Salazar, A. 152, 497
Fitzgerald, P.J., see Jeremias, A. 152, 209
Florentin, E., see Duvillard, L. 152, 229
Freedman, D.S., B.A. Bowman, J.D. Otvos, S.R. Srinivasan, G.S.
Berenson, Levels and correlates of LDL and VLDL particle sizes
among children: the Bogalusa heart study 152, 441
Friedlander, Y., E. Leitersdorf, R. Vecsler, H. Funke, J. Kark, The
contribution of candidate genes to the response of plasma lipids
and lipoproteins to dietary challenge 152, 239
Fruchart, J.-C., see Adlouni, A. 152, 433
Fruchart, J.-C., see Brites, F.D. 152, 181
Funke, H., see Friedlander, Y. 152, 239
Gallippi, P., see Renner, W. 152, 175
Gambert, P., see Duvillard, L. 152, 229
Gardemann, A., M. Philipp, K. Heß, N. Katz, H. Tillmanns, W.
Haberbosch, The paraoxonase Leu– Met54 and Gln– Arg191 gene
polymorphisms are not associated with the risk of coronary heart
disease 152, 421
Garvin, M.R., see O’Brien, E.R. 152, 117
Genest, J., Jr, see Mott, S. 152, 457
Gertler, R., see Kotzerke, J. 152, 35
Gevers Leuven, J.A., see de Man, F.H. 152, 407
Ghalim, N., see Adlouni, A. 152, 433
Ghanam, K., L. Ea-Kim, J. Javellaud, N. Oudart, Involvement of
potassium channels in the protective effect of 17b-estradiol on
hypercholesterolemic rabbit carotid artery 152, 59
Go´mez-Pe´rez, F.J., see Aguilar-Salinas, C.A. 152, 489
Gonza´lez, J.I., see Corella, D. 152, 367
Gonza´lez, L., see Romero, F. 152, 127
Griffin, M., see Leng, G.C. 152, 167
Grobbee, D.E., see Westendorp, I.C.D. 152, 149
Gudnason, V., see Wallace, A.J. 152, 327
Guille´n, L.E., see Aguilar-Salinas, C.A. 152, 489
Guille´n, M., see Corella, D. 152, 367
Gulı´as-Herrero, A., see Aguilar-Salinas, C.A. 152, 489
Gylling, H., see Relas, H. 152, 377
Haberbosch, W., see Gardemann, A. 152, 421
Hales, C.N., see Halsall, D.J. 152, 9
Halsall, D.J., N.D. Martensz, J. Luan, P. Maison, N.J. Wareham,
C.N. Hales, C.D. Byrne, A common apolipoprotein B signal
peptide polymorphism modifies the relation between plasma nonesterified fatty acids and triglyceride concentration in men 152, 9
Hamman, R.F., see Kamboh, M.I. 152, 193
Hassan, A., see Jeremias, A. 152, 209
He, J.L., see Lan Hsia, S. 152, 469
Heß, K., see Gardemann, A. 152, 421
Hinohara, T., see O’Brien, E.R. 152, 117
Hirano, K.-i., see Yamashita, S. 152, 271
Hirata, K.-i., see Rikitake, Y. 152, 79
Hofman, A., see Westendorp, I.C.D. 152, 149
Hombach, V., see Kotzerke, J. 152, 35
Horita, T., see Yasuda, S. 152, 337
Horne, D., see Lopes-Virella, M.F. 152, 107
Howes, J.B., D. Sullivan, N. Lai, P. Nestel, S. Pomeroy, L. West,
J.A. Eden, L.G. Howes, The effects of dietary supplementation
with isoflavones from red clover on the lipoprotein profiles of post
menopausal women with mild to moderate hypercholesterolaemia 152, 143
Howes, L.G., see Howes, J.B. 152, 143
Huang, J., see Knapp, A.C. 152, 217
Huegel, H., see Jeremias, A. 152, 209
Humphries, S.E., see Wallace, A.J. 152, 327
Hurtado, I., see Salazar, A. 152, 497
Ichikawa, K., see Yasuda, S. 152, 337
Inoue, N., see Rikitake, Y. 152, 79
Ishikawa, M., M. Akishita, K. Kozaki, K. Toba, A. Namiki, T.
Yamaguchi, H. Orimo, Y. Ouchi, Expression of parathyroid hormone-related protein in human and experimental atherosclerotic
lesions: functional role in arterial intimal thickening 152, 97
Javellaud, J., see Ghanam, K. 152, 59
Jeremias, A., H. Huegel, D.P. Lee, A. Hassan, A. Wolf, A.C. Yeung,
P.G. Yock, P.J. Fitzgerald, Spatial orientation of atherosclerotic
plaque in non-branching coronary artery segments 152, 209
Jokela, H., see Sillanaukee, P. 152, 503
Jokinen, E., see Tammi, A. 152, 135
Juhan-Vague, I., see Lopez, S. 152, 359
Kafatos, A., see Schiele, F. 152, 475
Kallionpa¨a¨, H., see Brigelius-Flohe´, R. 152, 307
Kamboh, M.I., C.E. Aston, R.F. Hamman, DNA sequence variation
in human apolipoprotein C4 gene and its effect on plasma lipid
profile 152, 193
Kark, J., see Friedlander, Y. 152, 239
Katz, N., see Gardemann, A. 152, 421
Kawai, Y., see Rikitake, Y. 152, 79
Kawashima, S., see Rikitake, Y. 152, 79
Khan, M.Y., see Okuda, K. 152, 391
Kiener, P.A., see Knapp, A.C. 152, 217
Author index 6ol. 152 (2000)
Kimura, M., see Okuda, K. 152, 391
Kimura, Y., see Tani, T. 152, 299
Klein, R., see Lopes-Virella, M.F. 152, 107
Knapp, A.C., J. Huang, G. Starling, P.A. Kiener, Inhibitors of
HMG-CoA reductase sensitize human smooth muscle cells to
Fas-ligand and cytokine-induced cell death 152, 217
Koike, T., see Yasuda, S. 152, 337
Koivula, T., see Sillanaukee, P. 152, 503
Koskinen, S., see Lopes-Virella, M.F. 152, 107
Kotzerke, J., R. Gertler, I. Buchmann, R. Baur, V. Hombach, S.
Norbert Reske, R. Voisard, Different radiosensitivity of smooth
muscle cells and endothelial cells in vitro as demonstrated by
irradiation from a Re-188 filled balloon catheter 152, 35
Kozaki, K., see Ishikawa, M. 152, 97
Krauss, C., see Renner, W. 152, 175
Kroon, A.A., M.A. van’t Hof, P.N.M. Demacker, A.F.H. Stalenhoef,
The rebound of lipoproteins after LDL-apheresis. Kinetics and
estimation of mean lipoprotein levels 152, 519
Kumar, S., see Li, C.G. 152, 249
Lai, N., see Howes, J.B. 152, 143
Lan Hsia, S., R. Duncan, A.H. Schob, S.C. Chakko, R. Mulingtapang, J.L. He, G.O. Perez, Serum levels of high-density lipoprotein
phospholipids correlate inversely with severity of angiographically
defined coronary artery disease 152, 469
Lapenna, D., see Baccante, G. 152, 51
Lapinleimu, H., see Tammi, A. 152, 135
Lee-Chen, G.-J., see Teng, Y.-N. 152, 385
Lee, D.P., see Jeremias, A. 152, 209
Lehtolainen, P., see Brigelius-Flohe´, R. 152, 307
Leitersdorf, E., see Friedlander, Y. 152, 239
Leng, G.C., O. Papacosta, P. Whincup, G. Wannamethee, M.
Walker, S. Ebrahim, A.N. Nicolaides, S. Dhanjil, M. Griffin, G.
Belcaro, A. Rumley, G.D.O. Lowe, Femoral atherosclerosis in an
older British population: prevalence and risk factors 152, 167
Li, C.G., H. Bethell, P.B. Wilson, D. Bhatnagar, M.G. Walker, S.
Kumar, The significance of CD105, TGFb and CD105/TGFb
complexes in coronary artery disease 152, 249
Lieber, C.S., see Navder, K.P. 152, 89
Lip, G.Y.H., see Blann, A.D. 152, 29
Lopes-Virella, M.F., S. Koskinen, M. Mironova, D. Horne, R. Klein,
C. Chassereau, C. Enockson, G. Virella, The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies
by EIA 152, 107
Lopez, S., F. Peiretti, B. Bonardo, I. Juhan-Vague, G. Nalbone,
Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial
cells 152, 359
Lo¨tzer, K., see Brigelius-Flohe´, R. 152, 307
Lowe, G.D.O., see Leng, G.C. 152, 167
Luan, J., see Halsall, D.J. 152, 9
Luc, G., J.-M. Bard, A. Evans, D. Arveiler, J.-B. Ruidavets, P.
Amouyel, P. Ducimetiere, The relationship between apolipoprotein
AI-containing lipoprotein fractions and environmental factors: the
prospective epidemiological study of myocardial infarction
(PRIME study) 152, 399
Maio, R., see Perticone, F. 152, 511
Maison, P., see Halsall, D.J. 152, 9
Man˜a, J., see Salazar, A. 152, 497
Mann, J.I., see Wallace, A.J. 152, 327
Marchioli, R., see Sirtori, C.R. 152, 1
Marcil, M., see Mott, S. 152, 457
Martensz, N.D., see Halsall, D.J. 152, 9
Martins, M.C., see Schiele, F. 152, 475
Marukawa, K., see Tani, T. 152, 299
Maruyama, T., see Yamashita, S. 152, 271
539
Masana, L., see Tahvanainen, E. 152, 317
Masood, I., see Salame, M.Y. 152, 19
Mastroroberto, P., see Perticone, F. 152, 511
Masuda, J., see Yamakawa, T. 152, 287
Matsuda, H., see Takemura, T. 152, 347
Matsuda, H., see Yamakawa, T. 152, 287
Matsumoto, K., S. Miyake, M. Yano, Y. Ueki, Y. Tominaga, High
serum concentrations of soluble E-selectin in patients with impaired
glucose tolerance with hyperinsulinemia 152, 415
Matsumura, T., see Takemura, T. 152, 347
Matsuura, E., see Yasuda, S. 152, 337
Matsuzawa, Y., see Yamashita, S. 152, 271
Mattioli, P.L., see Perticone, F. 152, 511
Maurer, S., see Brigelius-Flohe´, R. 152, 307
McCollum, C.N., see Blann, A.D. 152, 29
Meaney, E., see Aguilar-Salinas, C.A. 152, 489
Me´ndez, M.T., see Calleja, L. 152, 69
Mendoza Pe´rez, E., see Aguilar-Salinas, C.A. 152, 489
Miettinen, T.A., see Relas, H. 152, 377
Miles, E.A., F.A. Wallace, P.C. Calder, Dietary fish oil reduces
intercellular adhesion molecule 1 and scavenger receptor expression
on murine macrophages 152, 43
Mincione, G., see Baccante, G. 152, 51
Mironova, M., see Lopes-Virella, M.F. 152, 107
Miyake, S., see Matsumoto, K. 152, 415
Miyoshi, Y., see Yasuda, S. 152, 337
Moguel, R., see Aguilar-Salinas, C.A. 152, 489
Molin, M., see Tahvanainen, E. 152, 317
Mongiardo, A., see Perticone, F. 152, 511
Mott, S., L. Yu, M. Marcil, B. Boucher, C. Rondeau, J. Genest, Jr,
Decreased cellular cholesterol efflux is a common cause of familial
hypoalphalipoproteinemia: role of the ABCA1 gene mutations 152, 457
Mulet, F., see Corella, D. 152, 367
Mulingtapang, R., see Lan Hsia, S. 152, 469
Nakagawa, Y., see Rikitake, Y. 152, 79
Nakajima, N., see Yamashita, S. 152, 271
Nalbone, G., see Lopez, S. 152, 359
Namiki, A., see Ishikawa, M. 152, 97
Navder, K.P., E. Baraona, C.S. Lieber, Dilinoleoylphosphatidylcholine protects human low density lipoproteins against oxidation 152, 89
Nestel, P., see Howes, J.B. 152, 143
Nicaud, V., see Tahvanainen, E. 152, 317
Nicolaides, A.N., see Leng, G.C. 152, 167
Nieuwland, R., see de Man, F.H. 152, 407
Nishikawa, T., see Takemura, T. 152, 347
Norbert Reske, S., see Kotzerke, J. 152, 35
Novoa, G., see Aguilar-Salinas, C.A. 152, 489
O’Brien, E.R., S. Urieli-Shoval, M.R. Garvin, D.K. Stewart, T.
Hinohara, J.B. Simpson, E.P. Benditt, S.M. Schwartz, Replication
in restenotic atherectomy tissue 152, 117
Ogata, J., see Yamakawa, T. 152, 287
Okuda, K., M.Y. Khan, J. Skurnick, M. Kimura, H. Aviv, A. Aviv,
Telomere attrition of the human abdominal aorta: relationships
with age and atherosclerosis 152, 391
Ordova´s, J.M., see Corella, D. 152, 367
Orimo, H., see Ishikawa, M. 152, 97
Osada, J., see Calleja, L. 152, 69
Otvos, J.D., see Freedman, D.S. 152, 441
Ouchi, Y., see Ishikawa, M. 152, 97
Oudart, N., see Ghanam, K. 152, 59
Palacios-Alaiz, E., see Calleja, L. 152, 69
Pan, J.-P., see Teng, Y.-N. 152, 385
Author index 6ol. 152 (2000)
540
Papacosta, O., see Leng, G.C. 152, 167
Parra, G., see Romero, F. 152, 127
Parra, H.-J., see Adlouni, A. 152, 433
Pasolini, G., see Denti, L. 152, 159
Peiretti, F., see Lopez, S. 152, 359
Perez, G.O., see Lan Hsia, S. 152, 469
Perticone, F., R. Ceravolo, R. Maio, C. Cloro, M. Candigliota, A.
Scozzafava, A. Mongiardo, P. Mastroroberto, M. Chello, P.L.
Mattioli, Effects of atorvastatin and vitamin C on endothelial
function of hypercholesterolemic patients 152, 511
Philipp, M., see Gardemann, A. 152, 421
Pilger, E., see Renner, W. 152, 175
Pinto, X., see Salazar, A. 152, 497
Pitka¨ja¨rvi, T., see Sillanaukee, P. 152, 503
Planellas, J., see Westendorp, I.C.D. 152, 149
Pomeroy, S., see Howes, J.B. 152, 143
Pons, H., see Romero, F. 152, 127
Pont, F., see Duvillard, L. 152, 229
Porreca, E., see Baccante, G. 152, 51
Portole´s, O., see Corella, D. 152, 367
Posadas-Romero, C., see Aguilar-Salinas, C.A. 152, 489
Pujol, R., see Salazar, A. 152, 497
Quiroz, Y., see Romero, F.
152, 127
Reaven, G.M., see Chen, N.G. 152, 203
Relas, H., H. Gylling, T.A. Miettinen, Dietary squalene increases
cholesterol synthesis measured with serum non-cholesterol sterols
after a single oral dose in humans 152, 377
Renner, W., K. Schallmoser, P. Gallippi, C. Krauss, H. Toplak, T.C.
Wascher, E. Pilger, C242T polymorphism of the p22 phox gene is
not associated with peripheral arterial occlusive disease 152, 175
Rikitake, Y., K.-i. Hirata, S. Kawashima, N. Inoue, H. Akita, Y.
Kawai, Y. Nakagawa, M. Yokoyama, Inhibition of endotheliumdependent arterial relaxation by oxidized phosphatidylcholine 152, 79
Rinco´n, J., see Romero, F. 152, 127
Rodrı´guez-Iturbe, B., see Romero, F. 152, 127
Romero, F., B. Rodrı´guez-Iturbe, H. Pons, G. Parra, Y. Quiroz, J.
Rinco´n, L. Gonza´lez, Mycophenolate mofetil treatment reduces
cholesterol-induced atherosclerosis in the rabbit 152, 127
Romijn, F., see de Man, F.H. 152, 407
Rondeau, C., see Mott, S. 152, 457
Ro¨nnemaa, T., see Tammi, A. 152, 135
Rubins, H.B., see Sirtori, C.R. 152, 1
Ruidavets, J.-B., see Luc, G. 152, 399
Rumley, A., see Leng, G.C. 152, 167
Sagie, A., see Adler, Y. 152, 451
Sa´iz, C., see Corella, D. 152, 367
Sakai, M., see Takemura, T. 152, 347
Sakai, N., see Yamashita, S. 152, 271
Salame, M.Y., N.J. Samani, I. Masood, D.P. deBono, Expression of
the plasminogen activator system in the human vascular wall 152,
19
Salazar, A., J. Man˜a, C. Fiol, I. Hurtado, J.M. Argimon, R. Pujol, X.
Pinto, Influence of serum amyloid A on the decrease of high
density lipoprotein-cholesterol in active sarcoidosis 152, 497
Saı¨le, R., see Adlouni, A. 152, 433
Salinas-Orozco, S., see Aguilar-Salinas, C.A. 152, 489
Samani, N.J., see Salame, M.Y. 152, 19
Sanfelici, L., see Denti, L. 152, 159
Sans, S., see Schiele, F. 152, 475
Sasahara, T., see Takemura, T. 152, 347
Sass, C., see Schiele, F. 152, 475
Sawa, Y., see Yamakawa, T. 152, 287
Schallmoser, K., see Renner, W. 152, 175
Schiele, F., D. De Bacquer, M. Vincent-Viry, U. Beisiegel, C. Ehnholm, A. Evans, A. Kafatos, M.C. Martins, S. Sans, C. Sass, S.
Visvikis, G. De Backer, G. Siest, Apolipoprotein E serum concentration and polymorphism in six European countries: the
ApoEurope Project 152, 475
Schob, A.H., see Lan Hsia, S. 152, 469
Schwartz, S.M., see O’Brien, E.R. 152, 117
Scozzafava, A., see Perticone, F. 152, 511
Sela, N., see Adler, Y. 152, 451
Seppa¨, K., see Sillanaukee, P. 152, 503
Shapira, Y., see Adler, Y. 152, 451
Shichiri, M., see Takemura, T. 152, 347
Shirakura, R., see Yamakawa, T. 152, 287
Siest, G., see Schiele, F. 152, 475
Sillanaukee, P., T. Koivula, H. Jokela, T. Pitka¨ja¨rvi, K. Seppa¨,
Alcohol consumption and its relation to lipid-based cardiovascular
risk factors among middle-aged women: the role of HDL3 cholesterol 152, 503
Simell, O., see Tammi, A. 152, 135
Simpson, J.B., see O’Brien, E.R. 152, 117
Sirtori, C.R., L. Calabresi, R. Marchioli, H.B. Rubins, Cardiovascular risk changes after lipid lowering medications: are they predictable? 152, 1
Skeaff, C.M., see Wallace, A.J. 152, 327
Skurnick, J., see Okuda, K. 152, 391
Smelt, A.H.M., see de Man, F.H. 152, 407
Srinivasan, S.R., see Freedman, D.S. 152, 441
Stalenhoef, A.F.H., see Kroon, A.A. 152, 519
Starling, G., see Knapp, A.C. 152, 217
Stewart, D.K., see O’Brien, E.R. 152, 117
Sturk, A., see de Man, F.H. 152, 407
Sudo, T., see Tani, T. 152, 299
Sullivan, D., see Howes, J.B. 152, 143
Sutherland, W.H.F., see Wallace, A.J. 152, 327
Tahvanainen, E., M. Molin, S. Vainio, L. Tiret, V. Nicaud, E.
Farinaro, L. Masana, C. Ehnholm, Intestinal fatty acid binding
protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young
Europeans. Results from EARS II participants 152, 317
Tai, D.-Y., see Teng, Y.-N. 152, 385
Takemura, T., M. Sakai, H. Matsuda, T. Matsumura, T. Biwa, Y.
Anami, T. Nishikawa, T. Sasahara, M. Shichiri, Effects of probucol on cholesterol metabolism in mouse peritoneal macrophages:
inhibition of HDL-mediated cholesterol efflux 152, 347
Takeuchi, R., see Yasuda, S. 152, 337
Talmud, P.J., see Wallace, A.J. 152, 327
Tammi, A., T. Ro¨nnemaa, J. Viikari, E. Jokinen, H. Lapinleimu, C.
Ehnholm, O. Simell, Apolipoprotein E4 phenotype increases nonfasting serum triglyceride concentration in infants — the STRIP
study 152, 135
Tani, T., K. Uehara, T. Sudo, K. Marukawa, Y. Yasuda, Y. Kimura,
Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats 152, 299
Tanne, D., see Adler, Y. 152, 451
Teng, Y.-N., J.-P. Pan, S.-C. Chou, D.-Y. Tai, G.-J. Lee-Chen,
Familial defective apolipoprotein B-100: detection and haplotype
analysis of the Arg3500 Gln mutation in hyperlipidemic Chinese 152, 385
Tillmanns, H., see Gardemann, A. 152, 421
Tiret, L., see Tahvanainen, E. 152, 317
Toba, K., see Ishikawa, M. 152, 97
Tominaga, Y., see Matsumoto, K. 152, 415
Toplak, H., see Renner, W. 152, 175
Trallero, M.C., see Calleja, L. 152, 69
Tsutsumi, A., see Yasuda, S. 152, 337
Author index 6ol. 152 (2000)
Uehara, K., see Tani, T. 152, 299
Ueki, Y., see Matsumoto, K. 152, 415
Urieli-Shoval, S., see O’Brien, E.R. 152, 117
Vainio, S., see Tahvanainen, E. 152, 317
Valenti, G., see Denti, L. 152, 159
van der Laarse, A., see de Man, F.H. 152, 407
van’t Hof, M.A., see Kroon, A.A. 152, 519
Vaturi, M., see Adler, Y. 152, 451
Va´zquez-Cha´vez, C., see Aguilar-Salinas, C.A. 152, 489
Vecsler, R., see Friedlander, Y. 152, 239
Verge`s, B., see Duvillard, L. 152, 229
Viikari, J., see Tammi, A. 152, 135
Viita, H., see Brigelius-Flohe´, R. 152, 307
Vincent-Viry, M., see Schiele, F. 152, 475
Virella, G., see Lopes-Virella, M.F. 152, 107
Visvikis, S., see Schiele, F. 152, 475
Voisard, R., see Kotzerke, J. 152, 35
Walker, M.G., see Li, C.G. 152, 249
Walker, M., see Leng, G.C. 152, 167
Wallace, A.J., J.I. Mann, W.H.F. Sutherland, S. Williams, A.
Chisholm, C.M. Skeaff, V. Gudnason, P.J. Talmud, S.E.
Humphries, Variants in the cholesterol ester transfer protein and
lipoprotein lipase genes are predictors of plasma cholesterol response to dietary change 152, 327
Wallace, F.A., see Miles, E.A. 152, 43
Wannamethee, G., see Leng, G.C. 152, 167
Wareham, N.J., see Halsall, D.J. 152, 9
Wascher, T.C., see Renner, W. 152, 175
Weisenberg, D., see Adler, Y. 152, 451
Westendorp, I.C.D., M.J.J. de Kleijn, M.L. Bots, A.A.A. Bak, J.
Planellas, H.J.T. Coelingh Bennink, A. Hofman, D.E. Grobbee,
541
J.C.M. Witteman, The effect of hormone replacement therapy on
arterial distensibility and compliance in perimenopausal women: a
2-year randomised trial 152, 149
West, L., see Howes, J.B. 152, 143
Whincup, P., see Leng, G.C. 152, 167
Wikinski, R.W., see Brites, F.D. 152, 181
Williams, S., see Wallace, A.J. 152, 327
Wilson, P.B., see Li, C.G. 152, 249
Witteman, J.C.M., see Westendorp, I.C.D. 152, 149
Wolf, A., see Jeremias, A. 152, 209
Yael, M.J., see Brites, F.D. 152, 181
Yamaguchi, T., see Ishikawa, M. 152, 97
Yamakawa, T., H.-z. Bai, J. Masuda, Y. Sawa, R. Shirakura, J.
Ogata, H. Matsuda, Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas 152, 287
Yamashita, S., T. Maruyama, K.-i. Hirano, N. Sakai, N. Nakajima,
Y. Matsuzawa, Molecular mechanisms, lipoprotein abnormalities
and atherogenicity of hyperalphalipoproteinemia 152, 271
Yanai, H., see Yasuda, S. 152, 337
Yano, M., see Matsumoto, K. 152, 415
Yasuda, S., A. Tsutsumi, H. Chiba, H. Yanai, Y. Miyoshi, R.
Takeuchi, T. Horita, T. Atsumi, K. Ichikawa, E. Matsuura, T.
Koike, b2-glycoprotein I deficiency: prevalence, genetic background
and effects on plasma lipoprotein metabolism and hemostasis 152, 337
Yasuda, Y., see Tani, T. 152, 299
Yeung, A.C., see Jeremias, A. 152, 209
Yla¨-Herttuala, S., see Brigelius-Flohe´, R. 152, 307
Yock, P.G., see Jeremias, A. 152, 209
Yokoyama, M., see Rikitake, Y. 152, 79
Yu, L., see Mott, S. 152, 457
www.elsevier.com/locate/atherosclerosis
Author index
Volume 152 (2000)
Abbasi, F., see Chen, N.G. 152, 203
Ablondi, F., see Denti, L. 152, 159
Adler, Y., M. Vaturi, N. Fink, D. Tanne, Y. Shapira, D. Weisenberg,
N. Sela, A. Sagie, Association between mitral annulus calcification
and aortic atheroma: a prospective transesophageal echocardiographic study 152, 451
Adlouni, A., M. El Messal, R. Saı¨le, H.-J. Parra, J.-C. Fruchart, N.
Ghalim, Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein
AI-containing lipoprotein particles 152, 433
Aguilar-Salinas, C.A., F.J. Go´mez-Pe´rez, C. Posadas-Romero, C.
Va´zquez-Cha´vez, E. Meaney, A. Gulı´as-Herrero, L.E. Guille´n, A.
Alvarado Vega, E. Mendoza Pe´rez, L. Eduardo Romero-Nava, R.
Ange´lica Go´mez-Dı´az, S. Salinas-Orozco, R. Moguel, G. Novoa,
Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study 152, 489
Akishita, M., see Ishikawa, M. 152, 97
Akita, H., see Rikitake, Y. 152, 79
Alvarado Vega, A., see Aguilar-Salinas, C.A. 152, 489
Amiral, J., see Blann, A.D. 152, 29
Amouyel, P., see Luc, G. 152, 399
Anami, Y., see Takemura, T. 152, 347
Ange´lica Go´mez-Dı´az, R., see Aguilar-Salinas, C.A. 152, 489
Angelucci, D., see Baccante, G. 152, 51
Argimon, J.M., see Salazar, A. 152, 497
Arveiler, D., see Luc, G. 152, 399
Aston, C.E., see Kamboh, M.I. 152, 193
Atsumi, T., see Yasuda, S. 152, 337
Aviv, A., see Okuda, K. 152, 391
Aviv, H., see Okuda, K. 152, 391
Azhar, S., see Chen, N.G. 152, 203
Baccante, G., G. Mincione, C. Di Febbo, A. Coppa, D. Angelucci,
D. Lapenna, F. Cuccurullo, G. Colletta, E. Porreca, Increased type
II transforming growth factor-b receptor expression in liver cells
during cholesterol challenge 152, 51
Bai, H.-z., see Yamakawa, T. 152, 287
Bak, A.A.A., see Westendorp, I.C.D. 152, 149
Baraona, E., see Navder, K.P. 152, 89
Bard, J.-M., see Luc, G. 152, 399
Baur, R., see Kotzerke, J. 152, 35
Beisiegel, U., see Schiele, F. 152, 475
Belcaro, G., see Leng, G.C. 152, 167
Benditt, E.P., see O’Brien, E.R. 152, 117
Benedetti, R., see Denti, L. 152, 159
Berenson, G.S., see Freedman, D.S. 152, 441
Bethell, H., see Li, C.G. 152, 249
Bhatnagar, D., see Li, C.G. 152, 249
Biwa, T., see Takemura, T. 152, 347
Blann, A.D., J. Amiral, C.N. McCollum, G.Y.H. Lip, Differences in
free and total tissue factor pathway inhibitor, and tissue factor in
peripheral artery disease compared to healthy controls 152, 29
PII: S0021-9150(00)00650-X
Bo¨l, G.-F., see Brigelius-Flohe´, R. 152, 307
Bonardo, B., see Lopez, S. 152, 359
Bonavita, C.D., see Brites, F.D. 152, 181
Bots, M.L., see Westendorp, I.C.D. 152, 149
Boucher, B., see Mott, S. 152, 457
Bowman, B.A., see Freedman, D.S. 152, 441
Brigelius-Flohe´, R., S. Maurer, K. Lo¨tzer, G.-F. Bo¨l, H. Kallionpa¨a¨,
P. Lehtolainen, H. Viita, S. Yla¨-Herttuala, Overexpression of
PHGPx inhibits hydroperoxide-induced oxidation, NFkB activation and apoptosis and affects oxLDL-mediated proliferation of
rabbit aortic smooth muscle cells 152, 307
Brites, F.D., C.D. Bonavita, C. De Geitere, M. Cloe¨s, B. Delfly, M.J.
Yael, J.-C. Fruchart, R.W. Wikinski, G.R. Castro, Alterations in
the main steps of reverse cholesterol transport in male patients with
primary hypertriglyceridemia and low HDL-cholesterol levels 152, 181
Bruschieri, L., see Denti, L. 152, 159
Buchmann, I., see Kotzerke, J. 152, 35
Byrne, C.D., see Halsall, D.J. 152, 9
Calabresi, L., see Sirtori, C.R. 152, 1
Calder, P.C., see Miles, E.A. 152, 43
Calleja, L., M.C. Trallero, C. Carrizosa, M.T. Me´ndez, E. PalaciosAlaiz, J. Osada, Effects of dietary fat amount and saturation on the
regulation of hepatic mRNA and plasma apolipoprotein A-I in
rats 152, 69
Candigliota, M., see Perticone, F. 152, 511
Carantoni, M., see Chen, N.G. 152, 203
Carrizosa, C., see Calleja, L. 152, 69
Castro, G.R., see Brites, F.D. 152, 181
Cecchetti, A., see Denti, L. 152, 159
Ceravolo, R., see Perticone, F. 152, 511
Chakko, S.C., see Lan Hsia, S. 152, 469
Chassereau, C., see Lopes-Virella, M.F. 152, 107
Chello, M., see Perticone, F. 152, 511
Chen, N.G., S. Azhar, F. Abbasi, M. Carantoni, G.M. Reaven, The
relationship between plasma glucose and insulin responses to oral
glucose, LDL oxidation, and soluble intercellular adhesion
molecule-1 in healthy volunteers 152, 203
Chiba, H., see Yasuda, S. 152, 337
Chisholm, A., see Wallace, A.J. 152, 327
Chou, S.-C., see Teng, Y.-N. 152, 385
Cloe¨s, M., see Brites, F.D. 152, 181
Cloro, C., see Perticone, F. 152, 511
Coelingh Bennink, H.J.T., see Westendorp, I.C.D. 152, 149
Colletta, G., see Baccante, G. 152, 51
Coppa, A., see Baccante, G. 152, 51
Corella, D., C. Sa´iz, M. Guille´n, O. Portole´s, F. Mulet, J.I. Gonza´lez,
J.M. Ordova´s, Association of TaqIB polymorphism in the
cholesteryl ester transfer protein gene with plasma lipid levels in a
healthy Spanish population 152, 367
538
Author index 6ol. 152 (2000)
Cortellini, P., see Denti, L. 152, 159
Cuccurullo, F., see Baccante, G. 152, 51
De Backer, G., see Schiele, F. 152, 475
De Bacquer, D., see Schiele, F. 152, 475
deBono, D.P., see Salame, M.Y. 152, 19
De Geitere, C., see Brites, F.D. 152, 181
de Kleijn, M.J.J., see Westendorp, I.C.D. 152, 149
Delfly, B., see Brites, F.D. 152, 181
Demacker, P.N.M., see Kroon, A.A. 152, 519
de Man, F.H., R. Nieuwland, A. van der Laarse, F. Romijn, A.H.M.
Smelt, J.A. Gevers Leuven, A. Sturk, Activated platelets in patients
with severe hypertriglyceridemia: effects of triglyceride-lowering
therapy 152, 407
Denti, L., G. Pasolini, P. Cortellini, L. Sanfelici, R. Benedetti, A.
Cecchetti, S. Ferretti, L. Bruschieri, F. Ablondi, G. Valenti,
Changes in HDL-cholesterol and lipoprotein Lp(a) after 6-month
treatment with finasteride in males affected by benign prostatic
hyperplasia (BPH) 152, 159
Dhanjil, S., see Leng, G.C. 152, 167
Di Febbo, C., see Baccante, G. 152, 51
Ducimetiere, P., see Luc, G. 152, 399
Duncan, R., see Lan Hsia, S. 152, 469
Duvillard, L., F. Pont, E. Florentin, P. Gambert, B. Verge`s, Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic
abnormalities in non-insulin-dependent diabetes mellitus 152, 229
Ea-Kim, L., see Ghanam, K. 152, 59
Ebrahim, S., see Leng, G.C. 152, 167
Eden, J.A., see Howes, J.B. 152, 143
Eduardo Romero-Nava, L., see Aguilar-Salinas, C.A.
Ehnholm, C., see Schiele, F. 152, 475
Ehnholm, C., see Tahvanainen, E. 152, 317
Ehnholm, C., see Tammi, A. 152, 135
El Messal, M., see Adlouni, A. 152, 433
Enockson, C., see Lopes-Virella, M.F. 152, 107
Evans, A., see Luc, G. 152, 399
Evans, A., see Schiele, F. 152, 475
152, 489
Farinaro, E., see Tahvanainen, E. 152, 317
Ferretti, S., see Denti, L. 152, 159
Fink, N., see Adler, Y. 152, 451
Fiol, C., see Salazar, A. 152, 497
Fitzgerald, P.J., see Jeremias, A. 152, 209
Florentin, E., see Duvillard, L. 152, 229
Freedman, D.S., B.A. Bowman, J.D. Otvos, S.R. Srinivasan, G.S.
Berenson, Levels and correlates of LDL and VLDL particle sizes
among children: the Bogalusa heart study 152, 441
Friedlander, Y., E. Leitersdorf, R. Vecsler, H. Funke, J. Kark, The
contribution of candidate genes to the response of plasma lipids
and lipoproteins to dietary challenge 152, 239
Fruchart, J.-C., see Adlouni, A. 152, 433
Fruchart, J.-C., see Brites, F.D. 152, 181
Funke, H., see Friedlander, Y. 152, 239
Gallippi, P., see Renner, W. 152, 175
Gambert, P., see Duvillard, L. 152, 229
Gardemann, A., M. Philipp, K. Heß, N. Katz, H. Tillmanns, W.
Haberbosch, The paraoxonase Leu– Met54 and Gln– Arg191 gene
polymorphisms are not associated with the risk of coronary heart
disease 152, 421
Garvin, M.R., see O’Brien, E.R. 152, 117
Genest, J., Jr, see Mott, S. 152, 457
Gertler, R., see Kotzerke, J. 152, 35
Gevers Leuven, J.A., see de Man, F.H. 152, 407
Ghalim, N., see Adlouni, A. 152, 433
Ghanam, K., L. Ea-Kim, J. Javellaud, N. Oudart, Involvement of
potassium channels in the protective effect of 17b-estradiol on
hypercholesterolemic rabbit carotid artery 152, 59
Go´mez-Pe´rez, F.J., see Aguilar-Salinas, C.A. 152, 489
Gonza´lez, J.I., see Corella, D. 152, 367
Gonza´lez, L., see Romero, F. 152, 127
Griffin, M., see Leng, G.C. 152, 167
Grobbee, D.E., see Westendorp, I.C.D. 152, 149
Gudnason, V., see Wallace, A.J. 152, 327
Guille´n, L.E., see Aguilar-Salinas, C.A. 152, 489
Guille´n, M., see Corella, D. 152, 367
Gulı´as-Herrero, A., see Aguilar-Salinas, C.A. 152, 489
Gylling, H., see Relas, H. 152, 377
Haberbosch, W., see Gardemann, A. 152, 421
Hales, C.N., see Halsall, D.J. 152, 9
Halsall, D.J., N.D. Martensz, J. Luan, P. Maison, N.J. Wareham,
C.N. Hales, C.D. Byrne, A common apolipoprotein B signal
peptide polymorphism modifies the relation between plasma nonesterified fatty acids and triglyceride concentration in men 152, 9
Hamman, R.F., see Kamboh, M.I. 152, 193
Hassan, A., see Jeremias, A. 152, 209
He, J.L., see Lan Hsia, S. 152, 469
Heß, K., see Gardemann, A. 152, 421
Hinohara, T., see O’Brien, E.R. 152, 117
Hirano, K.-i., see Yamashita, S. 152, 271
Hirata, K.-i., see Rikitake, Y. 152, 79
Hofman, A., see Westendorp, I.C.D. 152, 149
Hombach, V., see Kotzerke, J. 152, 35
Horita, T., see Yasuda, S. 152, 337
Horne, D., see Lopes-Virella, M.F. 152, 107
Howes, J.B., D. Sullivan, N. Lai, P. Nestel, S. Pomeroy, L. West,
J.A. Eden, L.G. Howes, The effects of dietary supplementation
with isoflavones from red clover on the lipoprotein profiles of post
menopausal women with mild to moderate hypercholesterolaemia 152, 143
Howes, L.G., see Howes, J.B. 152, 143
Huang, J., see Knapp, A.C. 152, 217
Huegel, H., see Jeremias, A. 152, 209
Humphries, S.E., see Wallace, A.J. 152, 327
Hurtado, I., see Salazar, A. 152, 497
Ichikawa, K., see Yasuda, S. 152, 337
Inoue, N., see Rikitake, Y. 152, 79
Ishikawa, M., M. Akishita, K. Kozaki, K. Toba, A. Namiki, T.
Yamaguchi, H. Orimo, Y. Ouchi, Expression of parathyroid hormone-related protein in human and experimental atherosclerotic
lesions: functional role in arterial intimal thickening 152, 97
Javellaud, J., see Ghanam, K. 152, 59
Jeremias, A., H. Huegel, D.P. Lee, A. Hassan, A. Wolf, A.C. Yeung,
P.G. Yock, P.J. Fitzgerald, Spatial orientation of atherosclerotic
plaque in non-branching coronary artery segments 152, 209
Jokela, H., see Sillanaukee, P. 152, 503
Jokinen, E., see Tammi, A. 152, 135
Juhan-Vague, I., see Lopez, S. 152, 359
Kafatos, A., see Schiele, F. 152, 475
Kallionpa¨a¨, H., see Brigelius-Flohe´, R. 152, 307
Kamboh, M.I., C.E. Aston, R.F. Hamman, DNA sequence variation
in human apolipoprotein C4 gene and its effect on plasma lipid
profile 152, 193
Kark, J., see Friedlander, Y. 152, 239
Katz, N., see Gardemann, A. 152, 421
Kawai, Y., see Rikitake, Y. 152, 79
Kawashima, S., see Rikitake, Y. 152, 79
Khan, M.Y., see Okuda, K. 152, 391
Kiener, P.A., see Knapp, A.C. 152, 217
Author index 6ol. 152 (2000)
Kimura, M., see Okuda, K. 152, 391
Kimura, Y., see Tani, T. 152, 299
Klein, R., see Lopes-Virella, M.F. 152, 107
Knapp, A.C., J. Huang, G. Starling, P.A. Kiener, Inhibitors of
HMG-CoA reductase sensitize human smooth muscle cells to
Fas-ligand and cytokine-induced cell death 152, 217
Koike, T., see Yasuda, S. 152, 337
Koivula, T., see Sillanaukee, P. 152, 503
Koskinen, S., see Lopes-Virella, M.F. 152, 107
Kotzerke, J., R. Gertler, I. Buchmann, R. Baur, V. Hombach, S.
Norbert Reske, R. Voisard, Different radiosensitivity of smooth
muscle cells and endothelial cells in vitro as demonstrated by
irradiation from a Re-188 filled balloon catheter 152, 35
Kozaki, K., see Ishikawa, M. 152, 97
Krauss, C., see Renner, W. 152, 175
Kroon, A.A., M.A. van’t Hof, P.N.M. Demacker, A.F.H. Stalenhoef,
The rebound of lipoproteins after LDL-apheresis. Kinetics and
estimation of mean lipoprotein levels 152, 519
Kumar, S., see Li, C.G. 152, 249
Lai, N., see Howes, J.B. 152, 143
Lan Hsia, S., R. Duncan, A.H. Schob, S.C. Chakko, R. Mulingtapang, J.L. He, G.O. Perez, Serum levels of high-density lipoprotein
phospholipids correlate inversely with severity of angiographically
defined coronary artery disease 152, 469
Lapenna, D., see Baccante, G. 152, 51
Lapinleimu, H., see Tammi, A. 152, 135
Lee-Chen, G.-J., see Teng, Y.-N. 152, 385
Lee, D.P., see Jeremias, A. 152, 209
Lehtolainen, P., see Brigelius-Flohe´, R. 152, 307
Leitersdorf, E., see Friedlander, Y. 152, 239
Leng, G.C., O. Papacosta, P. Whincup, G. Wannamethee, M.
Walker, S. Ebrahim, A.N. Nicolaides, S. Dhanjil, M. Griffin, G.
Belcaro, A. Rumley, G.D.O. Lowe, Femoral atherosclerosis in an
older British population: prevalence and risk factors 152, 167
Li, C.G., H. Bethell, P.B. Wilson, D. Bhatnagar, M.G. Walker, S.
Kumar, The significance of CD105, TGFb and CD105/TGFb
complexes in coronary artery disease 152, 249
Lieber, C.S., see Navder, K.P. 152, 89
Lip, G.Y.H., see Blann, A.D. 152, 29
Lopes-Virella, M.F., S. Koskinen, M. Mironova, D. Horne, R. Klein,
C. Chassereau, C. Enockson, G. Virella, The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies
by EIA 152, 107
Lopez, S., F. Peiretti, B. Bonardo, I. Juhan-Vague, G. Nalbone,
Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial
cells 152, 359
Lo¨tzer, K., see Brigelius-Flohe´, R. 152, 307
Lowe, G.D.O., see Leng, G.C. 152, 167
Luan, J., see Halsall, D.J. 152, 9
Luc, G., J.-M. Bard, A. Evans, D. Arveiler, J.-B. Ruidavets, P.
Amouyel, P. Ducimetiere, The relationship between apolipoprotein
AI-containing lipoprotein fractions and environmental factors: the
prospective epidemiological study of myocardial infarction
(PRIME study) 152, 399
Maio, R., see Perticone, F. 152, 511
Maison, P., see Halsall, D.J. 152, 9
Man˜a, J., see Salazar, A. 152, 497
Mann, J.I., see Wallace, A.J. 152, 327
Marchioli, R., see Sirtori, C.R. 152, 1
Marcil, M., see Mott, S. 152, 457
Martensz, N.D., see Halsall, D.J. 152, 9
Martins, M.C., see Schiele, F. 152, 475
Marukawa, K., see Tani, T. 152, 299
Maruyama, T., see Yamashita, S. 152, 271
539
Masana, L., see Tahvanainen, E. 152, 317
Masood, I., see Salame, M.Y. 152, 19
Mastroroberto, P., see Perticone, F. 152, 511
Masuda, J., see Yamakawa, T. 152, 287
Matsuda, H., see Takemura, T. 152, 347
Matsuda, H., see Yamakawa, T. 152, 287
Matsumoto, K., S. Miyake, M. Yano, Y. Ueki, Y. Tominaga, High
serum concentrations of soluble E-selectin in patients with impaired
glucose tolerance with hyperinsulinemia 152, 415
Matsumura, T., see Takemura, T. 152, 347
Matsuura, E., see Yasuda, S. 152, 337
Matsuzawa, Y., see Yamashita, S. 152, 271
Mattioli, P.L., see Perticone, F. 152, 511
Maurer, S., see Brigelius-Flohe´, R. 152, 307
McCollum, C.N., see Blann, A.D. 152, 29
Meaney, E., see Aguilar-Salinas, C.A. 152, 489
Me´ndez, M.T., see Calleja, L. 152, 69
Mendoza Pe´rez, E., see Aguilar-Salinas, C.A. 152, 489
Miettinen, T.A., see Relas, H. 152, 377
Miles, E.A., F.A. Wallace, P.C. Calder, Dietary fish oil reduces
intercellular adhesion molecule 1 and scavenger receptor expression
on murine macrophages 152, 43
Mincione, G., see Baccante, G. 152, 51
Mironova, M., see Lopes-Virella, M.F. 152, 107
Miyake, S., see Matsumoto, K. 152, 415
Miyoshi, Y., see Yasuda, S. 152, 337
Moguel, R., see Aguilar-Salinas, C.A. 152, 489
Molin, M., see Tahvanainen, E. 152, 317
Mongiardo, A., see Perticone, F. 152, 511
Mott, S., L. Yu, M. Marcil, B. Boucher, C. Rondeau, J. Genest, Jr,
Decreased cellular cholesterol efflux is a common cause of familial
hypoalphalipoproteinemia: role of the ABCA1 gene mutations 152, 457
Mulet, F., see Corella, D. 152, 367
Mulingtapang, R., see Lan Hsia, S. 152, 469
Nakagawa, Y., see Rikitake, Y. 152, 79
Nakajima, N., see Yamashita, S. 152, 271
Nalbone, G., see Lopez, S. 152, 359
Namiki, A., see Ishikawa, M. 152, 97
Navder, K.P., E. Baraona, C.S. Lieber, Dilinoleoylphosphatidylcholine protects human low density lipoproteins against oxidation 152, 89
Nestel, P., see Howes, J.B. 152, 143
Nicaud, V., see Tahvanainen, E. 152, 317
Nicolaides, A.N., see Leng, G.C. 152, 167
Nieuwland, R., see de Man, F.H. 152, 407
Nishikawa, T., see Takemura, T. 152, 347
Norbert Reske, S., see Kotzerke, J. 152, 35
Novoa, G., see Aguilar-Salinas, C.A. 152, 489
O’Brien, E.R., S. Urieli-Shoval, M.R. Garvin, D.K. Stewart, T.
Hinohara, J.B. Simpson, E.P. Benditt, S.M. Schwartz, Replication
in restenotic atherectomy tissue 152, 117
Ogata, J., see Yamakawa, T. 152, 287
Okuda, K., M.Y. Khan, J. Skurnick, M. Kimura, H. Aviv, A. Aviv,
Telomere attrition of the human abdominal aorta: relationships
with age and atherosclerosis 152, 391
Ordova´s, J.M., see Corella, D. 152, 367
Orimo, H., see Ishikawa, M. 152, 97
Osada, J., see Calleja, L. 152, 69
Otvos, J.D., see Freedman, D.S. 152, 441
Ouchi, Y., see Ishikawa, M. 152, 97
Oudart, N., see Ghanam, K. 152, 59
Palacios-Alaiz, E., see Calleja, L. 152, 69
Pan, J.-P., see Teng, Y.-N. 152, 385
Author index 6ol. 152 (2000)
540
Papacosta, O., see Leng, G.C. 152, 167
Parra, G., see Romero, F. 152, 127
Parra, H.-J., see Adlouni, A. 152, 433
Pasolini, G., see Denti, L. 152, 159
Peiretti, F., see Lopez, S. 152, 359
Perez, G.O., see Lan Hsia, S. 152, 469
Perticone, F., R. Ceravolo, R. Maio, C. Cloro, M. Candigliota, A.
Scozzafava, A. Mongiardo, P. Mastroroberto, M. Chello, P.L.
Mattioli, Effects of atorvastatin and vitamin C on endothelial
function of hypercholesterolemic patients 152, 511
Philipp, M., see Gardemann, A. 152, 421
Pilger, E., see Renner, W. 152, 175
Pinto, X., see Salazar, A. 152, 497
Pitka¨ja¨rvi, T., see Sillanaukee, P. 152, 503
Planellas, J., see Westendorp, I.C.D. 152, 149
Pomeroy, S., see Howes, J.B. 152, 143
Pons, H., see Romero, F. 152, 127
Pont, F., see Duvillard, L. 152, 229
Porreca, E., see Baccante, G. 152, 51
Portole´s, O., see Corella, D. 152, 367
Posadas-Romero, C., see Aguilar-Salinas, C.A. 152, 489
Pujol, R., see Salazar, A. 152, 497
Quiroz, Y., see Romero, F.
152, 127
Reaven, G.M., see Chen, N.G. 152, 203
Relas, H., H. Gylling, T.A. Miettinen, Dietary squalene increases
cholesterol synthesis measured with serum non-cholesterol sterols
after a single oral dose in humans 152, 377
Renner, W., K. Schallmoser, P. Gallippi, C. Krauss, H. Toplak, T.C.
Wascher, E. Pilger, C242T polymorphism of the p22 phox gene is
not associated with peripheral arterial occlusive disease 152, 175
Rikitake, Y., K.-i. Hirata, S. Kawashima, N. Inoue, H. Akita, Y.
Kawai, Y. Nakagawa, M. Yokoyama, Inhibition of endotheliumdependent arterial relaxation by oxidized phosphatidylcholine 152, 79
Rinco´n, J., see Romero, F. 152, 127
Rodrı´guez-Iturbe, B., see Romero, F. 152, 127
Romero, F., B. Rodrı´guez-Iturbe, H. Pons, G. Parra, Y. Quiroz, J.
Rinco´n, L. Gonza´lez, Mycophenolate mofetil treatment reduces
cholesterol-induced atherosclerosis in the rabbit 152, 127
Romijn, F., see de Man, F.H. 152, 407
Rondeau, C., see Mott, S. 152, 457
Ro¨nnemaa, T., see Tammi, A. 152, 135
Rubins, H.B., see Sirtori, C.R. 152, 1
Ruidavets, J.-B., see Luc, G. 152, 399
Rumley, A., see Leng, G.C. 152, 167
Sagie, A., see Adler, Y. 152, 451
Sa´iz, C., see Corella, D. 152, 367
Sakai, M., see Takemura, T. 152, 347
Sakai, N., see Yamashita, S. 152, 271
Salame, M.Y., N.J. Samani, I. Masood, D.P. deBono, Expression of
the plasminogen activator system in the human vascular wall 152,
19
Salazar, A., J. Man˜a, C. Fiol, I. Hurtado, J.M. Argimon, R. Pujol, X.
Pinto, Influence of serum amyloid A on the decrease of high
density lipoprotein-cholesterol in active sarcoidosis 152, 497
Saı¨le, R., see Adlouni, A. 152, 433
Salinas-Orozco, S., see Aguilar-Salinas, C.A. 152, 489
Samani, N.J., see Salame, M.Y. 152, 19
Sanfelici, L., see Denti, L. 152, 159
Sans, S., see Schiele, F. 152, 475
Sasahara, T., see Takemura, T. 152, 347
Sass, C., see Schiele, F. 152, 475
Sawa, Y., see Yamakawa, T. 152, 287
Schallmoser, K., see Renner, W. 152, 175
Schiele, F., D. De Bacquer, M. Vincent-Viry, U. Beisiegel, C. Ehnholm, A. Evans, A. Kafatos, M.C. Martins, S. Sans, C. Sass, S.
Visvikis, G. De Backer, G. Siest, Apolipoprotein E serum concentration and polymorphism in six European countries: the
ApoEurope Project 152, 475
Schob, A.H., see Lan Hsia, S. 152, 469
Schwartz, S.M., see O’Brien, E.R. 152, 117
Scozzafava, A., see Perticone, F. 152, 511
Sela, N., see Adler, Y. 152, 451
Seppa¨, K., see Sillanaukee, P. 152, 503
Shapira, Y., see Adler, Y. 152, 451
Shichiri, M., see Takemura, T. 152, 347
Shirakura, R., see Yamakawa, T. 152, 287
Siest, G., see Schiele, F. 152, 475
Sillanaukee, P., T. Koivula, H. Jokela, T. Pitka¨ja¨rvi, K. Seppa¨,
Alcohol consumption and its relation to lipid-based cardiovascular
risk factors among middle-aged women: the role of HDL3 cholesterol 152, 503
Simell, O., see Tammi, A. 152, 135
Simpson, J.B., see O’Brien, E.R. 152, 117
Sirtori, C.R., L. Calabresi, R. Marchioli, H.B. Rubins, Cardiovascular risk changes after lipid lowering medications: are they predictable? 152, 1
Skeaff, C.M., see Wallace, A.J. 152, 327
Skurnick, J., see Okuda, K. 152, 391
Smelt, A.H.M., see de Man, F.H. 152, 407
Srinivasan, S.R., see Freedman, D.S. 152, 441
Stalenhoef, A.F.H., see Kroon, A.A. 152, 519
Starling, G., see Knapp, A.C. 152, 217
Stewart, D.K., see O’Brien, E.R. 152, 117
Sturk, A., see de Man, F.H. 152, 407
Sudo, T., see Tani, T. 152, 299
Sullivan, D., see Howes, J.B. 152, 143
Sutherland, W.H.F., see Wallace, A.J. 152, 327
Tahvanainen, E., M. Molin, S. Vainio, L. Tiret, V. Nicaud, E.
Farinaro, L. Masana, C. Ehnholm, Intestinal fatty acid binding
protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young
Europeans. Results from EARS II participants 152, 317
Tai, D.-Y., see Teng, Y.-N. 152, 385
Takemura, T., M. Sakai, H. Matsuda, T. Matsumura, T. Biwa, Y.
Anami, T. Nishikawa, T. Sasahara, M. Shichiri, Effects of probucol on cholesterol metabolism in mouse peritoneal macrophages:
inhibition of HDL-mediated cholesterol efflux 152, 347
Takeuchi, R., see Yasuda, S. 152, 337
Talmud, P.J., see Wallace, A.J. 152, 327
Tammi, A., T. Ro¨nnemaa, J. Viikari, E. Jokinen, H. Lapinleimu, C.
Ehnholm, O. Simell, Apolipoprotein E4 phenotype increases nonfasting serum triglyceride concentration in infants — the STRIP
study 152, 135
Tani, T., K. Uehara, T. Sudo, K. Marukawa, Y. Yasuda, Y. Kimura,
Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats 152, 299
Tanne, D., see Adler, Y. 152, 451
Teng, Y.-N., J.-P. Pan, S.-C. Chou, D.-Y. Tai, G.-J. Lee-Chen,
Familial defective apolipoprotein B-100: detection and haplotype
analysis of the Arg3500 Gln mutation in hyperlipidemic Chinese 152, 385
Tillmanns, H., see Gardemann, A. 152, 421
Tiret, L., see Tahvanainen, E. 152, 317
Toba, K., see Ishikawa, M. 152, 97
Tominaga, Y., see Matsumoto, K. 152, 415
Toplak, H., see Renner, W. 152, 175
Trallero, M.C., see Calleja, L. 152, 69
Tsutsumi, A., see Yasuda, S. 152, 337
Author index 6ol. 152 (2000)
Uehara, K., see Tani, T. 152, 299
Ueki, Y., see Matsumoto, K. 152, 415
Urieli-Shoval, S., see O’Brien, E.R. 152, 117
Vainio, S., see Tahvanainen, E. 152, 317
Valenti, G., see Denti, L. 152, 159
van der Laarse, A., see de Man, F.H. 152, 407
van’t Hof, M.A., see Kroon, A.A. 152, 519
Vaturi, M., see Adler, Y. 152, 451
Va´zquez-Cha´vez, C., see Aguilar-Salinas, C.A. 152, 489
Vecsler, R., see Friedlander, Y. 152, 239
Verge`s, B., see Duvillard, L. 152, 229
Viikari, J., see Tammi, A. 152, 135
Viita, H., see Brigelius-Flohe´, R. 152, 307
Vincent-Viry, M., see Schiele, F. 152, 475
Virella, G., see Lopes-Virella, M.F. 152, 107
Visvikis, S., see Schiele, F. 152, 475
Voisard, R., see Kotzerke, J. 152, 35
Walker, M.G., see Li, C.G. 152, 249
Walker, M., see Leng, G.C. 152, 167
Wallace, A.J., J.I. Mann, W.H.F. Sutherland, S. Williams, A.
Chisholm, C.M. Skeaff, V. Gudnason, P.J. Talmud, S.E.
Humphries, Variants in the cholesterol ester transfer protein and
lipoprotein lipase genes are predictors of plasma cholesterol response to dietary change 152, 327
Wallace, F.A., see Miles, E.A. 152, 43
Wannamethee, G., see Leng, G.C. 152, 167
Wareham, N.J., see Halsall, D.J. 152, 9
Wascher, T.C., see Renner, W. 152, 175
Weisenberg, D., see Adler, Y. 152, 451
Westendorp, I.C.D., M.J.J. de Kleijn, M.L. Bots, A.A.A. Bak, J.
Planellas, H.J.T. Coelingh Bennink, A. Hofman, D.E. Grobbee,
541
J.C.M. Witteman, The effect of hormone replacement therapy on
arterial distensibility and compliance in perimenopausal women: a
2-year randomised trial 152, 149
West, L., see Howes, J.B. 152, 143
Whincup, P., see Leng, G.C. 152, 167
Wikinski, R.W., see Brites, F.D. 152, 181
Williams, S., see Wallace, A.J. 152, 327
Wilson, P.B., see Li, C.G. 152, 249
Witteman, J.C.M., see Westendorp, I.C.D. 152, 149
Wolf, A., see Jeremias, A. 152, 209
Yael, M.J., see Brites, F.D. 152, 181
Yamaguchi, T., see Ishikawa, M. 152, 97
Yamakawa, T., H.-z. Bai, J. Masuda, Y. Sawa, R. Shirakura, J.
Ogata, H. Matsuda, Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas 152, 287
Yamashita, S., T. Maruyama, K.-i. Hirano, N. Sakai, N. Nakajima,
Y. Matsuzawa, Molecular mechanisms, lipoprotein abnormalities
and atherogenicity of hyperalphalipoproteinemia 152, 271
Yanai, H., see Yasuda, S. 152, 337
Yano, M., see Matsumoto, K. 152, 415
Yasuda, S., A. Tsutsumi, H. Chiba, H. Yanai, Y. Miyoshi, R.
Takeuchi, T. Horita, T. Atsumi, K. Ichikawa, E. Matsuura, T.
Koike, b2-glycoprotein I deficiency: prevalence, genetic background
and effects on plasma lipoprotein metabolism and hemostasis 152, 337
Yasuda, Y., see Tani, T. 152, 299
Yeung, A.C., see Jeremias, A. 152, 209
Yla¨-Herttuala, S., see Brigelius-Flohe´, R. 152, 307
Yock, P.G., see Jeremias, A. 152, 209
Yokoyama, M., see Rikitake, Y. 152, 79
Yu, L., see Mott, S. 152, 457